# Delivery Order #SPE2DR26FGJX9

DMS Pharmaceutical Protopam Chloride Delivery Order

**Buyer:** Defense Logistics Agency

**Award Amount:** $595.85
**Ceiling:** $595.85

**Awarded:** August 10, 2026
**Period of Performance:** Aug 10, 2026 - Aug 11, 2026

**Identifier:** SPE2DR26FGJX9
**NAICS:** 424210

This delivery order under a long-term pharmaceutical indefinite-delivery vehicle provides Protopam chloride, a medication supplied in one-gram vials, for the Defense Logistics Agency’s pharmaceutical supply needs. The recipient, DMS Pharmaceutical Group Inc., is a pharmaceutical supplier; no parent company is identified. The order’s stated scope is the specified Protopam product, with performance in Park Ridge, Illinois. The purchase supports access to a pharmaceutical product for government use, though the available record does not specify the end user or broader clinical purpose. The parent vehicle began in 2025 and is scheduled to continue through 2036; this order has a very short performance period in August 2026. The record does not state whether this order was competed or sole-source, identify an original solicitation or acquisition program, or list subcontractors or earlier related contracts beyond the parent vehicle.

### Description

4572885532!PROTOPAM CHLORIDE 1 GM VIALS

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DR26FGJX9_9700_SPE2DR25D9832_9700)
